Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.12 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.12 +0.00 (+0.24%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oramed Pharmaceuticals Stock Price Performance The Oramed Pharmaceuticals (ORMP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 15.87%, with a year-to-date return of -12.40%. In the past month, the stock has decreased 1.40%, reflecting recent market activity. As of the latest close, Oramed Pharmaceuticals traded at $2.12 with a market cap of $86.60 million and volume of 38,553 shares. Five years ago, the stock traded at $3.98, representing a 46.73% decrease over that period. At the time, it had a market cap of $96.00 million and a volume of 76,700 shares. Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.47%1 Month Performance-1.40%3 Month Performance-1.40%Year-To-Date Performance-12.40%1 Year Performance-15.87%5 Year Performance-46.73% ORMP Stock Chart for Friday, July, 18, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$2.12$2.12$2.15$2.0917,525 shs$86.60 million07/17/2025$2.11$2.12+0.47%$2.15$2.1038,553 shs$86.60 million07/16/2025$2.09$2.11+0.96%$2.11$2.1027,865 shs$86.19 million07/15/2025$2.13$2.09-1.88%$2.14$2.0981,490 shs$85.38 million07/14/2025$2.13$2.13$2.15$2.1156,784 shs$87.01 million07/11/2025$2.12$2.13+0.47%$2.16$2.1018,717 shs$87.01 million07/10/2025$2.17$2.12-2.30%$2.16$2.1126,946 shs$86.60 million07/09/2025$2.09$2.17+3.83%$2.20$2.1176,887 shs$88.64 million07/08/2025$2.16$2.09-3.24%$2.17$2.09104,189 shs$85.38 million07/07/2025$2.18$2.16-1.10%$2.22$2.1442,655 shs$88.24 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$2.18$2.18$2.20$2.1618,026 shs$89.22 million07/03/2025$2.16$2.18+1.11%$2.20$2.1618,026 shs$89.22 million07/02/2025$2.10$2.16+2.86%$2.19$2.1247,183 shs$88.24 million07/01/2025$2.25$2.10-6.67%$2.20$2.10117,830 shs$85.79 million06/30/2025$2.15$2.25+4.65%$2.25$2.11149,028 shs$91.91 million06/27/2025$2.17$2.15-0.92%$2.18$2.1059,111 shs$87.83 million06/26/2025$2.18$2.17-0.46%$2.19$2.1432,014 shs$88.64 million06/25/2025$2.17$2.18+0.46%$2.19$2.1326,985 shs$89.05 million06/24/2025$2.11$2.17+2.84%$2.21$2.07157,636 shs$88.64 million06/23/2025$2.13$2.11-0.94%$2.25$2.06141,792 shs$86.19 million06/20/2025$2.15$2.13-0.93%$2.17$2.0696,723 shs$87.01 million06/19/2025$2.15$2.15$2.20$2.1435,339 shs$87.83 million06/18/2025$2.16$2.15-0.46%$2.20$2.1435,339 shs$87.83 million06/17/2025$2.16$2.16$2.17$2.1423,221 shs$88.24 million Related Companies Humacyte Stock Chart Amarin Stock Chart Prothena Stock Chart Benitec Biopharma Stock Chart Heron Therapeutics Stock Chart SNDL Stock Chart Vor Biopharma Stock Chart Aura Biosciences Stock Chart Astria Therapeutics Stock Chart Aerovate Therapeutics Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 7/18/2025 by MarketBeat.com Staff From Our Partners[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredWhen your faith is put to the test, what will you do?Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORMP Stock Alerts